FDA Inspection
Ajanta Pharma LimitedAjanta Pharma Limited – FDA Inspection, Jun 23, 2023
Record Details
This FDA Inspection record concerns Ajanta Pharma Limited, with an inspection on June 23, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6544decf-02cf-4427-b5ce-f80dcd3dd2e4
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1210223
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Ajanta Pharma Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 27, 2018 | Not classified | Office of Inspections and Investigations | |
| February 9, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 7, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Ajanta Pharma Limited
- FDA Inspection 1098820 - 2019-06-22
- FDA Inspection 1065151 - 2018-07-27
- FDA Inspection 1045477 - 2018-02-09
- FDA Inspection 1017983 - 2017-04-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.